featured – Page 20

KMO inhibitor drug improves lifespan of Huntington's disease mice

Positive results from tests of a new 'KMO inhibiting' drug in Huntington's disease mice

June 2, 2011

Intermediate alleles and reduced penetrance – the genetic 'gray area' of Huntington’s disease, explained

April 22, 2011

Dimebon fails to improve symptoms in HD patients in the HORIZON trial

April 11, 2011

Is gene silencing as exciting as it sounds for HD, and what might the future hold?

March 22, 2011

HDBuzz interviews Graeme Bilbe, Global Head for Neuroscience at pharmaceutical giant Novartis, about their HD researc

March 14, 2011

HDBuzz interviews three top scientists from CHDI, the biggest funder and driver of HD research worldwide

February 25, 2011

Day 3 of CHDI’s HD therapeutics conference: growth factors and CHDI’s advanced therapies

February 10, 2011

Day 2 of CHDI’s HD therapeutics conference: figuring out energy problems in HD

February 9, 2011

Day 1 of CHDI’s HD therapeutics conference: exploring abnormal brain connections and silencing the HD gene

February 8, 2011

Welcome to HDBuzz. Huntington’s disease research news. In plain language. Written by scientists. For the global HD co

January 18, 2011